Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom
- PMID: 32734679
- DOI: 10.1111/coa.13616
Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom
Abstract
Objectives: We aimed to audit current United Kingdom (UK) practice of Head and Neck Cancer (HNC) post-treatment surveillance against national guidelines and determine the outcomes of these practices in detecting recurrence.
Design: National cross-sectional study of current HNC surveillance practice.
Setting: UK HNC outpatient departments.
Participants: HNC patients reviewed for post-treatment surveillance.
Main outcome measures: Compliance with UK multidisciplinary guidelines and rates of cancer recurrence detection by time, clinic type and symptoms.
Results: Data were analysed from 5,123 consultations across 89 UK centres. 30% of consultations were in dedicated multidisciplinary clinics, with input from allied health professionals (AHPs) available on the day in 23% of all consultations. Recurrence was suspected in 344 consultations and investigated with MRI in 29.6% (n = 102) and PET-CT in 14.2% (n = 49). Patient education regarding recurrence symptoms, and smoking and alcohol advice, was provided in 20.4%, 6.2% and 5.3% of cases, respectively. Rates of recurrence detected were 35% in expedited appointments and 5.2% in planned follow-ups (P = .0001). Of the expedited appointments, 63% were initiated by patients and 37% by clinicians. Recurrence was higher in those with new symptoms (7.1% versus 2.2%). The strongest predictors of recurrence were dyspnoea (positive predictive value (PPV)=16.2%), neck pain (PPV = 10.4%) and mouth/throat pain (PPV = 9.2%).
Conclusions: Dedicated multidisciplinary clinics comprise a minority of consultations for HNC surveillance in the UK, with low availability of AHPs. PET-CT and MRI were underutilised for the investigation of suspected recurrence. There may be scope for greater emphasis on patient education and consequent patient-initiated symptom-driven follow-up.
Keywords: audit; cancer; guidelines; head and neck; recurrence; surveillance; treatment.
© 2020 John Wiley & Sons Ltd.
References
REFERENCES
-
- Cohen EE , LaMonte SJ , Erb NL , et al. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66:203-239.
-
- De Felice F , de Vincentiis M , Valentini V , et al. Follow-up program in head and neck cancer. Crit. Rev. Oncol. Hematol. 2017;113:151-155.
-
- Simo R , Homer J , Clarke P , et al. Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S208-S211.
-
- Kothari P , Trinidade A , Hewitt RJD , Singh A , O’Flynn P . The follow-up of patients with head and neck cancer: an analysis of 1,039 patients. Eur Arch Otorhinolaryngol. 2011;268:1191-1200.
-
- Rocke J , Mclaren O , Hardman J , et al. The role of allied healthcare professionals in head and neck cancer surveillance: A systematic review. Clin Otolaryngol. 2020;45:83-98.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
